<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2013.1341</article-id>
<article-id pub-id-type="publisher-id">mmr-07-04-1129</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Evaluation of the proliferation and differentiation behaviors of mesenchymal stem cells with partially converted borate glass containing different amounts of strontium <italic>in vitro</italic></article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>ZHU</surname><given-names>YI</given-names></name><xref rid="af1-mmr-07-04-1129" ref-type="aff">1</xref><xref rid="fn1-mmr-07-04-1129" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>OUYANG</surname><given-names>YUANMING</given-names></name><xref rid="af1-mmr-07-04-1129" ref-type="aff">1</xref><xref rid="fn1-mmr-07-04-1129" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>CHANG</surname><given-names>YI</given-names></name><xref rid="af2-mmr-07-04-1129" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>LUO</surname><given-names>CONGFENG</given-names></name><xref rid="af1-mmr-07-04-1129" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>JUN</given-names></name><xref rid="af1-mmr-07-04-1129" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-mmr-07-04-1129"/></contrib>
<contrib contrib-type="author">
<name><surname>ZHANG</surname><given-names>CHANGQING</given-names></name><xref rid="af1-mmr-07-04-1129" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>HUANG</surname><given-names>WENHAI</given-names></name><xref rid="af3-mmr-07-04-1129" ref-type="aff">3</xref></contrib></contrib-group>
<aff id="af1-mmr-07-04-1129">
<label>1</label>Department of Orthopaedic Surgery, Shanghai Sixth People&#x02019;s Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China</aff>
<aff id="af2-mmr-07-04-1129">
<label>2</label>Department of Plastic Surgery, Shanghai Sixth People&#x02019;s Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China</aff>
<aff id="af3-mmr-07-04-1129">
<label>3</label>Institute of Bioengineering and Information Technology Materials, Tongji University, Shanghai 200092, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-07-04-1129">Correspondence to: Dr Jun Xu, Department of Orthopaedic Surgery, Shanghai Sixth People&#x02019;s Hospital, Shanghai Jiaotong University, 600 Yishan Road, Shanghai 200233, P.R. China, E-mail: <email>junxu19781214@gmail.com</email></corresp><fn id="fn1-mmr-07-04-1129">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>02</month>
<year>2013</year></pub-date>
<volume>7</volume>
<issue>4</issue>
<fpage>1129</fpage>
<lpage>1136</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2012</year></date>
<date date-type="accepted">
<day>22</day>
<month>01</month>
<year>2013</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>The objective of this study was to examine the proliferation and differentiation behaviors of different compositions of strontium-containing (from 0&#x02013;12 mol&#x00025;) borate glasses with mesenchymal stem cells (MSCs). The Cell Counting Kit-8 (CCK-8) assay revealed that after three days of culturing, the 6Sr group had the highest cell growth rate. Analysis of cell morphology revealed that cells proliferated well near the particles of the samples in all the groups on day 3. On day 7, cells in the 6Sr group demonstrated a higher proliferation rate than other 4 groups under the microscope. When performing the Live-Dead staining experiment, the 6Sr group had the least number of dead cells. Total DNA qualification indicated that the 6Sr group had a statistically higher concentration compared with the remaining groups. It was found that on day 7, compared with the 0Sr group, the core binding factor &#x003B1;1 (Cbfa1) mRNA expression level was significantly higher in the 6Sr, 9Sr and 12Sr groups. On day 14, compared with the 0Sr group, the bone sialoprotein (BSP) mRNA level was significantly higher in the 6Sr group. Additionally, on day 21, the 6Sr and 9Sr groups demonstrated higher osteocalcin (OCN) mRNA expression levels compared with the 0Sr group. In the alkaline phosphatase (ALP) activity test, on day 21, the 6Sr group presented a higher activity than the 0Sr group. Further, the number of mineralized nodules per unit in MSCs was measured by Alizarin Red S staining. The results showed that the 6Sr and 9Sr groups had the greatest number of mineralized nodules. Therefore, it could be concluded that borate glasses containing strontium oxide of 0, 3, 6, 9 and 12 mol&#x00025; demonstrate a significant level of proliferation when interacting with MSCs. The borate glass containing 6 mol&#x00025; strontium oxide had the greatest level of proliferation when cultured with MSCs. The borate glass containing 6 and 9 mol&#x00025; strontium oxide facilitated an improved bone formation ability compared with the remaining two compositions.</p></abstract>
<kwd-group>
<kwd>borate glass</kwd>
<kwd>strontium</kwd>
<kwd>proliferation</kwd>
<kwd>differentiation</kwd>
<kwd>mesenchymal stem cell</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Bioactive glasses have attractive behaviors for biomedical substitutes, and provide a biological alternative for bone and tissue regeneration (<xref rid="b1-mmr-07-04-1129" ref-type="bibr">1</xref>,<xref rid="b2-mmr-07-04-1129" ref-type="bibr">2</xref>). For example, silicate-based bioglass, such as 45S5 glass (<xref rid="b3-mmr-07-04-1129" ref-type="bibr">3</xref>), has been most widely studied for its biomedical applications (<xref rid="b4-mmr-07-04-1129" ref-type="bibr">4</xref>). Due to its incomplete degradation behaviors (<xref rid="b5-mmr-07-04-1129" ref-type="bibr">5</xref>), 45S5 glass has gradually been replaced by the bioactive borate glass (<xref rid="b6-mmr-07-04-1129" ref-type="bibr">6</xref>), which has a similar composition to 45S5 glass, but all the SiO<sub>2</sub> is replaced with B<sub>2</sub>O<sub>3</sub>. The new composition has a faster degradation ability and a higher conversion rate than silicate 45S5 glass. It has been suggested that borate glass could be applied in the field of tissue engineering (<xref rid="b7-mmr-07-04-1129" ref-type="bibr">7</xref>,<xref rid="b8-mmr-07-04-1129" ref-type="bibr">8</xref>).</p>
<p>To the best of our knowledge, strontium is a trace element in humans and has been applied as a medication, such as strontium ranelate in the treatment of osteoporosis. Sr<sup>2&#x0002B;</sup> has been found to promote osteogenic differentiation of mesenchymal stem cells (MSCs) (<xref rid="b9-mmr-07-04-1129" ref-type="bibr">9</xref>&#x02013;<xref rid="b11-mmr-07-04-1129" ref-type="bibr">11</xref>), stimulate osteoblast proliferation (<xref rid="b12-mmr-07-04-1129" ref-type="bibr">12</xref>,<xref rid="b13-mmr-07-04-1129" ref-type="bibr">13</xref>) and accelerate osteoclast apoptosis (<xref rid="b14-mmr-07-04-1129" ref-type="bibr">14</xref>). Moreover, incorporating strontium into bioactive glass improves the bioactivity of bone repair (<xref rid="b15-mmr-07-04-1129" ref-type="bibr">15</xref>) and bone formation (<xref rid="b16-mmr-07-04-1129" ref-type="bibr">16</xref>). Therefore, we hypothesized that strontium-containing bioactive borate glass would have improved cell compatibility in tissue engineering.</p>
<p>The purpose of our study was to evaluate the proliferation and differentiation effects of strontium in borate glass on MSCs <italic>in vitro</italic>. Additionally, we attempted to determine an appropriate composition of strontium in borate glass for future applications <italic>in vivo</italic>.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Sample preparation</title>
<sec>
<title>Biomaterials synthesis</title>
<p>The preparation of the glass samples by melting and casting processes was performed as described previously (<xref rid="b16-mmr-07-04-1129" ref-type="bibr">16</xref>,<xref rid="b17-mmr-07-04-1129" ref-type="bibr">17</xref>). Generally, the glass samples with the composition of Na<sub>2</sub>O-K<sub>2</sub>O-MgO-CaO-B<sub>2</sub>O<sub>3</sub>-SiO<sub>2</sub>-SrO-P<sub>2</sub>O<sub>5</sub> (<xref rid="tI-mmr-07-04-1129" ref-type="table">Table I</xref>) were prepared by melting each analytical chemical in a platinum crucible at 1,500&#x000B0;C for 2 h with stirring, and then quenching the melt between cold stainless steel plates into glass flakes. These flakes were used as glass wafers (1-mm thick) in the assay experiments, while some of the glass flakes were crushed into fine particles (105&#x02013;125 &#x003BC;m in size) and used for the extraction experiments.</p>
<p>Prior to all the experiments, the particles or flakes were soaked in 0.025 M K<sub>2</sub>HPO<sub>4</sub> solution for 10 days to allow for the superficial reaction and to avoid the fast borate-releasing stage occurring during the following the experimental processes (<xref rid="b18-mmr-07-04-1129" ref-type="bibr">18</xref>,<xref rid="b19-mmr-07-04-1129" ref-type="bibr">19</xref>). Scanning electron microscope (SEM) observation was performed following the soaking of samples and the partial conversion to hydroxyapatite on the surface of borate glass particles, and prior to commencing the experiments (<xref rid="f1-mmr-07-04-1129" ref-type="fig">Fig. 1</xref>).</p></sec>
<sec>
<title>Sample degradation</title>
<p>Assessment of the <italic>in vitro</italic> degradation of strontium in borate glass for each group was conducted by statically immersing the glass particles of each group (1 g) in 0.02 M K<sub>2</sub>HPO<sub>4</sub> solution (100 ml; pH 7.0) at 37&#x000B0;C for 28 days. The strontium in the immersion solution at different time points was analyzed by ion chromatography (DX 500 Dionex, USA). The average values were obtained from three parallel experiment samples. The accumulated released irons of strontium at different time points were calculated by the weight of the strontium in the solution divided by that in the original samples.</p></sec>
<sec>
<title>MSC culture</title>
<p>Canine bone marrow-derived mesenchymal stem cells (MSCs) were used in the present experiment. The animal study was approved by the Committee of Medical Ethics and the Institutional Review Board of Shanghai Sixth People&#x02019;s Hospital, Shanghai Jiaotong University (China). MSCs were isolated by density gradient centrifugation following iliac bone marrow aspiration. The cells were resuspended in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM; Gibco-BRL, Carlsbad, CA, USA) supplemented with 10&#x00025; fetal bovine serum (FBS; Thermo Scientific, HyClone, Logan, UT, USA), 100 IU/ml penicillin (Gibco-BRL) and 100 lg/ml streptomycin (Gibco-BRL), and cultured at 37&#x000B0;C in 5&#x00025; CO<sub>2</sub> and 95&#x00025; humidity. After culturing for 7 days in the 75-cm<sup>2</sup> flask, the adherent cells (passage 0) were washed with phosphate-buffered saline (PBS), and then fresh medium was added every 3&#x02013;4 days. Following the initiation of cultures for 2 weeks, the cells were washed with PBS, and then lifted by incubation in 0.5 ml of 0.25&#x00025; trypsin and 1 mM ethylenediaminetetraacetic acid for 2 min at room temperature. Trypsin was neutralized by adding 2 ml complete medium. Each flask of cells was passaged into 75-cm<sup>2</sup> culture flasks every 3&#x02013;4 days. After primary culturing for 2 weeks, the second passage MSCs were successfully harvested and used in this study (<xref rid="f2-mmr-07-04-1129" ref-type="fig">Fig. 2</xref>).</p></sec></sec>
<sec>
<title>Proliferation</title>
<sec>
<title>Cell Counting Kit-8 (CCK-8) assay</title>
<p>The extraction solutions were prepared by immersing 75 mg partially converted glass particles (average diameter, 105&#x02013;125 &#x003BC;m) in 10 ml culture medium in a CO<sub>2</sub> incubator at 37&#x000B0;C for 24 h, to ensure the specific surface areas reached 6 cm<sup>2</sup>/ml (according to DS/EN ISO 10993-12:2009). Subsequently, MSCs (passage 2) were seeded in 96-well plates at a density of 1&#x000D7;10<sup>4</sup> cells/well in 100 &#x003BC;l FBS culture medium, in a CO<sub>2</sub> incubator at 37&#x000B0;C for 24 h. The medium in the well was then replaced with the prepared extraction solution. After 3 days, the CCK-8 (Dojindo Molecular Technologies, Inc., Rockville, MD, USA) with 10 &#x003BC;l CCK-8 was added to each well using a repeating pipettor, and then mixed on an orbital shaker for 1 min. Following incubation for 2 h, the absorbance of each well was measured spectrophotometrically at 450 nm. Three parallel replicates of each sample at each time point were prepared during the cell viability assay. Statistical analyses were performed using a one-way ANOVA.</p></sec>
<sec>
<title>Cell morphology</title>
<p>The 60-mm petri dishes with affixed partially converted glass particles (105&#x02013;125 &#x003BC;m; 6 cm<sup>2</sup>/ml) for each group (A-E, as in <xref rid="tI-mmr-07-04-1129" ref-type="table">Table I</xref>) were placed on a small platform rocker in the CO<sub>2</sub> incubator to gently mix in 10 ml culture medium prior to incubation. The rocking cycle consisted of 1 min on and 5 min off. Passage 2 MSCs cells were seeded with culture medium at an initial density of 15,000 cells/cm<sup>2</sup> and incubated at 37&#x000B0;C in a humidified atmosphere of 5&#x00025; CO<sub>2</sub>. The phase contrast images of MSCs at the interface of each group were observed after 3 and 7 days of culturing.</p></sec>
<sec>
<title>Live-Dead cell staining</title>
<p>Similarly, MSCs cells were seeded in the medium containing each group of glass particles (6cm<sup>2</sup>/ml) at a density of 15,000 cells/cm<sup>2</sup>. After culturing for 7 days, the cells mixed with particles were rinsed with warm PBS twice and incubated for an additional 30 min in serum-free DMEM containing 2 mM calcein acetoxymethyl ester (calcein AM; Biotium, Hayward, CA, USA) and 1 &#x003BC;g/ml propidium iodide (Sigma-Aldrich, USA). The fluorochrome-labeled cultures on the glass wafers were then rinsed with PBS and examined under an epifluorescent microscope fitted with appropriate exciter and emitter filters to detect live (green fluorescent) and dead (red fluorescent) cells.</p></sec>
<sec>
<title>DNA quantification</title>
<p>The global effects of the glass particles with different compositions on the proliferation of MSC cells were assessed by measuring the total cellular DNA content in cultures incubated with the glass particles in place. Triplicate samples of each glass group were added to MSC cultures in 60-mm petri dishes and incubated for 7 days. Following incubation, the cultures were rinsed twice with PBS. The DNA on all dishes was extracted using the TIANamp Genomic DNA kit (Tiangen Biotech, Beijing, China) according to the manufacturer&#x02019;s instructions. The quantification of DNA concentration in each group was measured by a UV spectrophotometer (Eppendorf, Hamburg, Germany).</p></sec>
<sec>
<title>Differentiation</title>
<p>MSCs were cultured in 60-mm petri dishes affixed with partially converted glass particles for each group (A-E, as in <xref rid="tI-mmr-07-04-1129" ref-type="table">Table I</xref>) at an initial seeding density of 15,000 cells/cm<sup>2</sup>. DMEM supplemented with 10&#x00025; fetal bovine serum and 1&#x00025; antibiotics mixture (100 &#x003BC;g/ml of penicillin and streptomycin) were used as the culture medium. After being grown to confluence, the culture medium of each group was replaced with osteogenic induction medium, containing 10<sup>&#x02212;8</sup> M dexamethasone, 0.2 mM ascorbic acid-phosphate and 10 mM &#x003B2;-glycerophosphate (Sigma-Aldrich, Co., St. Louis, MO, USA). Cells were incubated at 37&#x000B0;C, 5&#x00025; CO<sub>2</sub> and 95&#x00025; humidity, and the medium was replaced every 2 days.</p></sec>
<sec>
<title>Real-time reverse transcription-polymerase chain reaction (RT-PCR)</title>
<p>Total RNA of each group was extracted from cells in the 60-mm petri dishes using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Total RNA (2 &#x003BC;g) was reverse transcribed into cDNA using the cDNA kit (Takara Biotechnology, Dalian, China) according to the manufacturer&#x02019;s instructions. Real-time PCR was then performed to examine the expression of osteogenic genes and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels in the MSCs. The expression levels of each gene were standardized by the internal control levels of GAPDH. Amplification was denatured at 94&#x000B0;C for 5 min, followed by 30 cycles of denaturation at 94&#x000B0;C for 1 min; then annealed at 54&#x000B0;C for 30 sec and 72&#x000B0;C for 1 min. The temperature was then returned to 95&#x000B0;C and samples were stored at 4&#x000B0;C overnight. These procedures were performed in a PCR machine (Eppendorf).</p>
<p>The primer sequences used were: Forward: 5&#x02032;-CCGCACGA CAACCGCACCAT-3&#x02032; and reverse: 5&#x02032;-CGCTCCGGCCCA CAAATCTC-3&#x02032; for core binding factor &#x003B1;1 (Cbfa1); forward: 5&#x02032;-CAGTAGTGACTCATCCGAAG-3&#x02032; and reverse: 5&#x02032;-CTCCTCTTCTTCTTCATCAC-3&#x02032; for bone sialoprotein (BSP); forward: 5&#x02032;-CACCGAGACACCATGAGAGC-3&#x02032; and reverse: 5&#x02032;-TGGTCAGCCAACTCGTCAC-3&#x02032; for osteocalcin (OCN); forward: 5&#x02032;-CTTTTAACTCTGGTAAAGTGG-3&#x02032; and reverse: 5&#x02032;-TTTTGGCTCCCCCCTGCAAAT-3&#x02032; for GAPDH.</p></sec>
<sec>
<title>Alkaline phosphatase (ALP) activity</title>
<p>After 14 and 21 days of culturing, the cells were washed twice with PBS, placed in 500 &#x003BC;l of 1&#x00025; Triton X-100, and lysed using two freeze-thaw cycles (&#x02212;80/37&#x000B0;C). Aliquots of the lysate were placed in a 96-well plate for spectrophotometric measurement of ALP activity with p-nitrophenyl phosphate (PNPP) substrate, as previously described (<xref rid="b17-mmr-07-04-1129" ref-type="bibr">17</xref>). ALP activity was normalized with respect to the total protein content obtained from the same cell lysate, and was expressed as nanomoles of PNPP formed per microgram of protein per minute. Total protein content was determined using the Micro-Bicinchoninic acid (BCA) Protein Assay kit (Pierce Biotechnologies, Rockford, IL, USA), according to the manufacturer&#x02019;s instructions.</p></sec>
<sec>
<title>Alizarin Red S staining</title>
<p>Alizarin Red S staining of MSC cultures was conducted after 21 days of culturing. The culture medium was removed from each well and cells were rinsed three times with PBS. After fixing with 4&#x00025; formaldehyde solution for 30 min at room temperature, the cells were rinsed twice with PBS and fixed cells were stained with 1 ml of 2&#x00025; Alizarin Red S working solution (Sigma-Aldrich) and incubated for 10&#x02013;20 min at 37&#x000B0;C. Cells were then rinsed three times and visualized under an optical microscope. The number of mineralized nodules per unit was counted.</p></sec></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Sample preparation</title>
<sec>
<title>Characterization of degradation</title>
<p>During immersion in phosphate solution, the ions of strontium changed over time. As shown in <xref rid="f3-mmr-07-04-1129" ref-type="fig">Fig. 3</xref>, the concentration reached a stable level after &#x02265;20 days. From the curve, we found that in the solution, the levels of strontium released from the borate glass were relative to its composition in each group, the more strontium the particles contained, the higher the concentration in the corresponding soaking solution.</p></sec></sec>
<sec>
<title>Proliferation</title>
<sec>
<title>CCK-8 assay</title>
<p>Results of the CCK-8 assay demonstrated the growth rates of the different groups relative to that of the control group with DMEM&#x0002B;FBS. After culturing for three days, the relative growth rates in the groups containing strontium were between 1.0 and 1.5. The 6Sr group demonstrated a significant difference. However, the 0Sr group demonstrated the lowest relative growth rate (<xref rid="f4-mmr-07-04-1129" ref-type="fig">Fig. 4</xref>).</p></sec>
<sec>
<title>Cell morphology</title>
<p><xref rid="f5-mmr-07-04-1129" ref-type="fig">Fig. 5</xref> shows the cell morphology (on days 3 and 7) of MSCs incubated with the strontium-containing borate glass particles of different compositions. The optical microscope revealed that all cells proliferated well along the borate glass particles. Additionally, the glass particles and the MSCs were 70&#x00025; confluent, which was consistent with the results of the CCK-8 assay. On day 7, the 6Sr group showed the greatest amount of proliferation of MSCs among all the groups.</p></sec>
<sec>
<title>Live-Dead assay</title>
<p>The Live-Dead assay (<xref rid="f6-mmr-07-04-1129" ref-type="fig">Fig. 6</xref>) provided a direct observation of the proportion of living and dead cells. All the groups showed increased cell proliferation on day 7. The 6Sr group exhibited the least number of dead cells and the greatest number of living cells, on staining. Other groups showed a relatively higher proportion of dead cells than the 6Sr group.</p></sec>
<sec>
<title>Total DNA concentration</title>
<p>Total DNA concentration, cell growth at the genetic level, indicated that the 6Sr group demonstrated the highest concentration, statistically, than any other group (<xref rid="f7-mmr-07-04-1129" ref-type="fig">Fig. 7</xref>).</p></sec></sec>
<sec>
<title>Differentiation</title>
<sec>
<title>Real-time RT-PCR</title>
<p>In our experiment, the expression of early, middle and late osteogenic genes in primary canine bone marrow MSCs was examined using real-time RT-PCR on days 7, 14, and 21, respectively, to analyse MSC maturation. It was found that on day 7, compared with the 0Sr group, the Cbfa1 mRNA expression level was significantly higher in the 6Sr, 9Sr and 12Sr groups (P&lt;0.01). On day 14, compared with the 0Sr group, the BSP mRNA level was significantly higher in the 6Sr group (P&lt;0.01). In addition, on day 21, similar to BSP expression, groups 6Sr and 9Sr exhibited higher OCN mRNA expression levels than the 0Sr group (P&lt;0.01) (<xref rid="f8-mmr-07-04-1129" ref-type="fig">Fig. 8</xref>).</p></sec>
<sec>
<title>ALP activity</title>
<p>The results of the spectrophotometric measurement of ALP activity of MSCs in all the groups are presented in <xref rid="f9-mmr-07-04-1129" ref-type="fig">Fig. 9</xref>. On day 14, ALP levels in groups with strontium showed no significant differences compared with the 0Sr group. However, on day 21, the 6Sr group demonstrated a higher ALP activity than the 0Sr group (P&lt;0.01). Moreover, at both time points, the groups containing strontium had a higher ALP level than the 0Sr group. However, the difference was only statistically significant in the 6Sr group on day 21.</p></sec>
<sec>
<title>Alizarin Red S staining</title>
<p>Alizarin Red S staining was used to examine the mineralized nodule formation by MSCs cultured with different contents of strontium-incorporated borate medium for 21 days (<xref rid="f10-mmr-07-04-1129" ref-type="fig">Fig. 10</xref>). Measured by Alizarin Red S staining, the number of mineralized nodules per unit in MSCs was also counted. The result showed that groups 6Sr and 9Sr had the greatest number of mineralized nodules (<xref rid="f11-mmr-07-04-1129" ref-type="fig">Fig. 11</xref>).</p></sec></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Bioglass has attracted increasing attention since it was produced in 1971 (<xref rid="b3-mmr-07-04-1129" ref-type="bibr">3</xref>,<xref rid="b6-mmr-07-04-1129" ref-type="bibr">6</xref>). Bioactive glasses and glass-ceramic systems are famous for their excellent biocompatibility and bioactivity in bone tissue engineering (<xref rid="b20-mmr-07-04-1129" ref-type="bibr">20</xref>). After advances in industrial techniques and preparation configuration, silicate bioactive glass has gradually been replaced by borate bioactive glass, which has a wider range of bioactivity and degradation rates, with stronger bone formation in combination with hydroxyapatite for tissue regeneration. However, silicate bioactive glass has certain disadvantages: It converts slowly and incompletely to hyaluronic acid (HA) when placed in body fluid, and it is difficult to sinter 45S5 particles into a porous three-dimensional (3D) network (<xref rid="b7-mmr-07-04-1129" ref-type="bibr">7</xref>). Moreover, borate-based bioactive glasses have been developed for their potential biomedical advantages (<xref rid="b21-mmr-07-04-1129" ref-type="bibr">21</xref>).</p>
<p>Borosilicate scaffolds with the fastest degradation rate are toxic to cells, likely due to the high concentration of boron ions released into the medium (<xref rid="b15-mmr-07-04-1129" ref-type="bibr">15</xref>). Increased cell proliferation has been demonstrated to occur when &lt;2/3 of the SiO<sub>2</sub> in 45S5 glass was replaced by B<sub>2</sub>O<sub>3</sub> in a borosilicate glass composition, or by partially converting the borate glass to HA prior to cell culture (<xref rid="b17-mmr-07-04-1129" ref-type="bibr">17</xref>). Alternatively, dynamic culturing (<xref rid="b17-mmr-07-04-1129" ref-type="bibr">17</xref>) and minor element incorporation would both achieve a biologically acceptable rate of borate release. Notably, strontium is a trace element in the human body and has been demonstrated to play a unique role in bone remodeling by stimulating bone formation and reducing bone resorption (<xref rid="b22-mmr-07-04-1129" ref-type="bibr">22</xref>,<xref rid="b23-mmr-07-04-1129" ref-type="bibr">23</xref>). As a result, we proposed that strontium-containing borate glass particles would have a higher superficial degradation rate, and that an improved compatibility and proliferation of the MSCs may be observed.</p>
<p>Cytocompatibility behavior with stem cells is an important procedure to assess a novel material prior to application in tissue engineering. In the present study, all the 6Sr groups demonstrated a high relative growth rate after culturing for 3 days. The optical microscopy results revealed that following mixed culturing with MSC cells for 7 days, all groups showed good proliferation. However, the 6Sr group demonstrated the optimum growth performance, both under optical observation and the Live-Dead cell staining. It has been demonstrated that the concentration of boron released from glass incorporating strontium was 2-fold lower than that released from borate glass (<xref rid="b16-mmr-07-04-1129" ref-type="bibr">16</xref>). As the radius of the strontium ion is larger than that of a magnesium or calcium ion, the strontium ion occupies more space in the glass network, and effectively inhibits the movement and release of other ions. Therefore, borate release from the glass particles can be controlled by altering the strontium oxide content in the glass composition. This explains why different compositions of strontium have different growth rates. To investigate the proliferation ability of the strontium-containing borate glass among the five different compositions of strontium, the total DNA concentration following mixed culturing for 7 days was examined in each group. The results indicated that the 6Sr group had the highest DNA quantification, providing evidence of improved proliferation activity in this group. From a molecular biological perspective, a greater amount of proliferation activity and improved duplicate ability may be evident in the strontium-containing groups, particularly in the 6Sr group. However, the detailed underlying mechanism requires further study. Consequently, the cytotoxicity of the rapid release of boron was minimized, and incorporating strontium into borate glass may be regarded as an effective way to promote MSC proliferation.</p>
<p>During differentiation towards mature osteoblasts, a number of extracellular matrix genes are expressed by MSCs. For instance, Cbfa1 is a transcription factor in the early osteogenetic stage. BSP and OCN are regarded as the middle and late stage gene markers of bone formation, respectively. In the present study, the expression of these early, middle and late osteogenic genes in primary canine bone marrow MSCs was examined using real-time RT-PCR on days 7, 14 and 21, respectively, to analyze MSC maturation. On day 7, compared with the 0Sr group, the Cbfa1 mRNA level was significantly higher in groups 6Sr, 9Sr and 12Sr (P&lt;0.01). The results were consistent with a previous study that demonstrated the higher Cbfa1 mRNA performance of the 5&#x02013;10&#x00025; strontium-substituted HA (Sr-HA) ceramics (<xref rid="b9-mmr-07-04-1129" ref-type="bibr">9</xref>). Furthermore, on day 14, compared with the 0Sr group, the BSP mRNA expression level was significantly higher in the 6Sr group. In addition, on day 21, groups 6Sr and 9Sr exhibited higher OCN mRNA expression levels than the 0Sr group (P&lt;0.01). It was found that 6&#x02013;9&#x00025; strontium-substituted borate glass provided an improved osteogenetic ability for MSCs compared with 0&#x02013;3&#x00025; strontium-substituted borate glass. It has also been demonstrated that strontium may promote the differentiation of MSCs through activation of the BSP and OCN genes in the middle and late stages of osteogenesis. However, the 12Sr group demonstrated poor ability in the process of bone formation, suggesting a negative feedback mechanism may affect the regulation of strontium in osteoblastic differentiation when the concentration of strontium is at a relatively higher level (<xref rid="b9-mmr-07-04-1129" ref-type="bibr">9</xref>).</p>
<p>ALP is an important marker for osteogenic cell derivatives of MSCs. Previously, it demonstrated elevated levels when grown on 45S5 bioactive glass compared with tissue culture (<xref rid="b24-mmr-07-04-1129" ref-type="bibr">24</xref>). As shown in the present study, the 6Sr group exhibited the highest ALP excretion after the 21 days of culturing. The data demonstrated that the 6Sr group is a reliable indication for the differentiation of MSCs into the osteoblastic lineage. Similarly, Alizarin Red S staining is an intuitionistic method to examine the mineralization capacity. In our experiments, the medium in all the groups was stained red under a microscope. It may be that the strontium-containing borate glass is able to promote MSC secretion of the osteogenetic substance. In particular, in the 6Sr group, the obvious mineralized nodules were observed. These results were consistent with previous <italic>in vitro</italic> studies regarding the stimulatory effect of various strontium-incorporated materials, that Sr-HA ceramics may enhance osteoblastic cell differentiation and mineralization (<xref rid="b25-mmr-07-04-1129" ref-type="bibr">25</xref>,<xref rid="b26-mmr-07-04-1129" ref-type="bibr">26</xref>).</p>
<p>Strontium stimulates bone formation through its positive action on osteoblastic differentiation and function, as well as by decreasing osteoclast differentiation and function (<xref rid="b27-mmr-07-04-1129" ref-type="bibr">27</xref>). The potential mechanism may involve the fact that both Sr<sup>2&#x0002B;</sup> and SiO<sup>4&#x02212;</sup> ions enhance ALP activity in human bone MSCs (<xref rid="b15-mmr-07-04-1129" ref-type="bibr">15</xref>). Furthermore, it has been demonstrated that strontium ranelate increases the replication of cells of the osteoblastic lineage by two distinct cell mechanisms involving CaSR, and triggering mitogenic signals, such as p38, in C3H10T1/2 cells. It has been suggested that the release of an autocrine growth factor by strontium is another potential mechanism for inducing osteoblastic cell replication (<xref rid="b28-mmr-07-04-1129" ref-type="bibr">28</xref>). The detailed mechanism of strengthened bone formation by strontium requires further study.</p>
<p>In conclusion, borate glasses containing strontium oxide of 0, 3, 6, 9 and 12 mol&#x00025; demonstrate significant levels of proliferation when interacting with MSCs. The borate glass containing 6 mol&#x00025; strontium oxide has the best characteristic of proliferation when cultured with MSCs. The borate glass containing 6 and 9 mol&#x00025; strontium oxide facilitates improved bone formation ability compared with the remaining two compositions. Overall, it may be concluded that borate glass containing strontium provides a promising material in tissue engineering, and that 6 mol&#x00025; strontium oxide in borate glass could facilitate maximum proliferation and differentiation abilities.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The study was supported by the National Natural Science Foundation projects (Nos. C160802, 81000788 and 51072133). The authors would like to thank Professor Wenhai Huang (Institute of Bioengineering and Information Technology Materials, Tongji University, Shanghai, China) for his instructions and reviewing of the study.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-07-04-1129"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Brown</surname><given-names>RF</given-names></name><name><surname>Bal</surname><given-names>BS</given-names></name><name><surname>Day</surname><given-names>DE</given-names></name></person-group><article-title>Bioactive glasses for nonbearing applications in total joint replacement</article-title><source>Semin Arthroplasty</source><volume>17</volume><fpage>102</fpage><lpage>112</lpage><year>2006</year></element-citation></ref>
<ref id="b2-mmr-07-04-1129"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Gentleman</surname><given-names>E</given-names></name><name><surname>Polak</surname><given-names>J</given-names></name></person-group><article-title>Bioactive glass scaffolds for bone regeneration</article-title><source>Elements</source><volume>3</volume><fpage>393</fpage><lpage>399</lpage><year>2007</year></element-citation></ref>
<ref id="b3-mmr-07-04-1129"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Splinter</surname><given-names>RJ</given-names></name><name><surname>Allen</surname><given-names>WC</given-names></name><name><surname>Greenlee</surname><given-names>TK</given-names></name></person-group><article-title>Bonding mechanisms at the interface of ceramic prosthetic materials</article-title><source>J Biomed Mater Res</source><volume>5</volume><fpage>117</fpage><lpage>141</lpage><year>1971</year></element-citation></ref>
<ref id="b4-mmr-07-04-1129"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name></person-group><article-title>Surface-active biomaterials</article-title><source>Science</source><volume>226</volume><fpage>630</fpage><lpage>636</lpage><year>1984</year></element-citation></ref>
<ref id="b5-mmr-07-04-1129"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamadouche</surname><given-names>M</given-names></name><name><surname>Meunier</surname><given-names>A</given-names></name><name><surname>Greenspan</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Long-term <italic>in vivo</italic> bioactivity and degradability of bulk sol-gel bioactive glasses</article-title><source>J Biomed Mater Res</source><volume>54</volume><fpage>560</fpage><lpage>566</lpage><year>2001</year></element-citation></ref>
<ref id="b6-mmr-07-04-1129"><label>6</label><element-citation publication-type="thesis"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>MNC</given-names></name></person-group><article-title>Bioactive Behavior of a Borate Glass</article-title><source>MS Thesis</source><publisher-name>University of Missouri-Rolla</publisher-name><year>2000</year></element-citation></ref>
<ref id="b7-mmr-07-04-1129"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I Preparation and in vitro degradation</article-title><source>J Biomed Mater Res A</source><volume>95</volume><fpage>164</fpage><lpage>171</lpage><year>2010</year></element-citation></ref>
<ref id="b8-mmr-07-04-1129"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Bal</surname><given-names>BS</given-names></name><name><surname>Bonewald</surname><given-names>LF</given-names></name><name><surname>Kuroki</surname><given-names>K</given-names></name><name><surname>Brown</surname><given-names>RF</given-names></name></person-group><article-title>Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II In vitro and in vivo biological evaluation</article-title><source>J Biomed Mater Res A</source><volume>95</volume><fpage>172</fpage><lpage>179</lpage><year>2010</year></element-citation></ref>
<ref id="b9-mmr-07-04-1129"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sila-Asna</surname><given-names>M</given-names></name><name><surname>Bunyaratvej</surname><given-names>A</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Kitaguchi</surname><given-names>H</given-names></name><name><surname>Bunyaratavej</surname><given-names>N</given-names></name></person-group><article-title>Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell</article-title><source>Kobe J Med Sci</source><volume>53</volume><fpage>25</fpage><lpage>35</lpage><year>2007</year></element-citation></ref>
<ref id="b10-mmr-07-04-1129"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Tu</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling</article-title><source>Stem Cells</source><volume>29</volume><fpage>981</fpage><lpage>991</lpage><year>2011</year></element-citation></ref>
<ref id="b11-mmr-07-04-1129"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Luk</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway</article-title><source>Cell Physiol Biochem</source><volume>23</volume><fpage>165</fpage><lpage>174</lpage><year>2009</year></element-citation></ref>
<ref id="b12-mmr-07-04-1129"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verberckmoes</surname><given-names>SC</given-names></name><name><surname>De Broe</surname><given-names>ME</given-names></name><name><surname>D&#x02019;Haese</surname><given-names>PC</given-names></name></person-group><article-title>Dose-dependent effects of strontium on osteoblast function and mineralization</article-title><source>Kidney Int</source><volume>64</volume><fpage>534</fpage><lpage>543</lpage><year>2003</year></element-citation></ref>
<ref id="b13-mmr-07-04-1129"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>XJ</given-names></name><name><surname>Wan</surname><given-names>CX</given-names></name><name><surname>Zhao</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name></person-group><article-title>Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds</article-title><source>Biomaterials</source><volume>27</volume><fpage>1277</fpage><lpage>1286</lpage><year>2006</year></element-citation></ref>
<ref id="b14-mmr-07-04-1129"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurtel-Lemaire</surname><given-names>AS</given-names></name><name><surname>Mentaverri</surname><given-names>R</given-names></name><name><surname>Caudrillier</surname><given-names>A</given-names></name><etal/></person-group><article-title>The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways</article-title><source>J Biol Chem</source><volume>284</volume><fpage>575</fpage><lpage>584</lpage><year>2009</year></element-citation></ref>
<ref id="b15-mmr-07-04-1129"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Gelinsky</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bioactive SrO-SiO2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties</article-title><source>Acta Biomater</source><volume>7</volume><fpage>1797</fpage><lpage>1806</lpage><year>2011</year></element-citation></ref>
<ref id="b16-mmr-07-04-1129"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>HB</given-names></name><name><surname>Zhao</surname><given-names>XL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Strontium borate glass: potential biomaterial for bone regeneration</article-title><source>J R Soc Interface</source><volume>7</volume><fpage>1025</fpage><lpage>1031</lpage><year>2010</year></element-citation></ref>
<ref id="b17-mmr-07-04-1129"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RF</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Dwilewicz</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells</article-title><source>J Biomed Mater Res A</source><volume>88</volume><fpage>392</fpage><lpage>400</lpage><year>2009</year></element-citation></ref>
<ref id="b18-mmr-07-04-1129"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Day</surname><given-names>DE</given-names></name><name><surname>Kittiratanapiboon</surname><given-names>K</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name></person-group><article-title>Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions</article-title><source>J Mater Sci Mater Med</source><volume>17</volume><fpage>583</fpage><lpage>596</lpage><year>2006</year></element-citation></ref>
<ref id="b19-mmr-07-04-1129"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Bioactive borosilicate glass scaffolds: in vitro degradation and bioactivity behaviors</article-title><source>J Mater Sci Mater Med</source><volume>20</volume><fpage>1237</fpage><lpage>1243</lpage><year>2009</year></element-citation></ref>
<ref id="b20-mmr-07-04-1129"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Day</surname><given-names>DE</given-names></name><name><surname>Bal</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Bioactive glass in tissue engineering</article-title><source>Acta Biomater</source><volume>7</volume><fpage>2355</fpage><lpage>2373</lpage><year>2011</year></element-citation></ref>
<ref id="b21-mmr-07-04-1129"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>DEWJ</given-names></name><name><surname>Brown</surname><given-names>RF</given-names></name><name><surname>McMenamin</surname><given-names>KD</given-names></name></person-group><article-title>Transformation of borate glasses into biologically useful materials</article-title><source>Glass Technol</source><volume>44</volume><fpage>75</fpage><lpage>81</lpage><year>2003</year></element-citation></ref>
<ref id="b22-mmr-07-04-1129"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reginster</surname><given-names>JY</given-names></name></person-group><article-title>Strontium ranelate in osteoporosis</article-title><source>Curr Pharm Des</source><volume>8</volume><fpage>1907</fpage><lpage>1916</lpage><year>2002</year></element-citation></ref>
<ref id="b23-mmr-07-04-1129"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buehler</surname><given-names>J</given-names></name><name><surname>Chappuis</surname><given-names>P</given-names></name><name><surname>Saffar</surname><given-names>JL</given-names></name><name><surname>Tsouderos</surname><given-names>Y</given-names></name><name><surname>Vignery</surname><given-names>A</given-names></name></person-group><article-title>Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (<italic>Macaca fascicularis</italic>)</article-title><source>Bone</source><volume>29</volume><fpage>176</fpage><lpage>179</lpage><year>2001</year></element-citation></ref>
<ref id="b24-mmr-07-04-1129"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>GC</given-names></name><name><surname>Radin</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>AT</given-names></name><name><surname>Ducheyne</surname><given-names>P</given-names></name></person-group><article-title>Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass</article-title><source>Biomaterials</source><volume>28</volume><fpage>4091</fpage><lpage>4097</lpage><year>2007</year></element-citation></ref>
<ref id="b25-mmr-07-04-1129"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>GX</given-names></name><name><surname>Yao</surname><given-names>ZP</given-names></name><name><surname>Huang</surname><given-names>GT</given-names></name><name><surname>Liu</surname><given-names>WG</given-names></name><name><surname>Lu</surname><given-names>WW</given-names></name></person-group><article-title>The effect of strontium incorporation in hydroxyapatite on osteoblasts in vitro</article-title><source>J Mater Sci Mater Med</source><volume>22</volume><fpage>961</fpage><lpage>967</lpage><year>2011</year></element-citation></ref>
<ref id="b26-mmr-07-04-1129"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentleman</surname><given-names>E</given-names></name><name><surname>Fredholm</surname><given-names>YC</given-names></name><name><surname>Jell</surname><given-names>G</given-names></name><etal/></person-group><article-title>The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro</article-title><source>Biomaterials</source><volume>31</volume><fpage>3949</fpage><lpage>3956</lpage><year>2010</year></element-citation></ref>
<ref id="b27-mmr-07-04-1129"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnelye</surname><given-names>E</given-names></name><name><surname>Chabadel</surname><given-names>A</given-names></name><name><surname>Saltel</surname><given-names>F</given-names></name><name><surname>Jurdic</surname><given-names>P</given-names></name></person-group><article-title>Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro</article-title><source>Bone</source><volume>42</volume><fpage>129</fpage><lpage>138</lpage><year>2008</year></element-citation></ref>
<ref id="b28-mmr-07-04-1129"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caverzasio</surname><given-names>J</given-names></name></person-group><article-title>Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms</article-title><source>Bone</source><volume>42</volume><fpage>1131</fpage><lpage>1136</lpage><year>2008</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-07-04-1129" position="float">
<label>Figure 1</label>
<caption>
<p>Scanning electron microscope (SEM) micrographs of the surfaces of the borate glass particles used in the cell culture experiments after soaking for 10 days at 37&#x000B0;C in the 0.025 M K<sub>2</sub>HPO<sub>4</sub> solutions: (A) 3Sr group, &#x000D7;10,000; (B) 3Sr group, &#x000D7;40,000 times; (C) 6Sr group, &#x000D7;10,000; (D) 6Sr group, &#x000D7;40,000; (E) 12Sr group, &#x000D7;10,000; (F) 12Sr group, &#x000D7;40,000.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g00.gif"/></fig>
<fig id="f2-mmr-07-04-1129" position="float">
<label>Figure 2</label>
<caption>
<p>Photomicrographs of bone barrow-derived mesenchymal stem cells, passage 2: (A) day 1, (B) day 3 and (C) day 7.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g01.gif"/></fig>
<fig id="f3-mmr-07-04-1129" position="float">
<label>Figure 3</label>
<caption>
<p>Accumulation of strontium leaching from the corresponding immersing solution of each group.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g02.gif"/></fig>
<fig id="f4-mmr-07-04-1129" position="float">
<label>Figure 4</label>
<caption>
<p>Relative growth rate of mesenchymal stem cells (MSCs) after culturing for 3 days with the different groups, using Dulbecco&#x02019;s modified Eagle&#x02019;s medium and fetal bovine serum (DMEM&#x0002B;FBS) as the control. Mean &#x000B1; standard deviation; n&#x0003D;3. <sup>&#x0002A;</sup>Significantly different from the DMEM&#x0002B;FBS group at P&lt;0.05.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g03.gif"/></fig>
<fig id="f5-mmr-07-04-1129" position="float">
<label>Figure 5</label>
<caption>
<p>Photomicrographs of mesenchymal stem cell (MSC) proliferation after (A) 3 and (B) 7 days of culturing with the different groups.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g04.gif"/></fig>
<fig id="f6-mmr-07-04-1129" position="float">
<label>Figure 6</label>
<caption>
<p>Live-Dead cell staining of mesenchymal stem cells (MSCs) after culturing for 7 days with each group. Living cells were detected as green fluorescence and dead cells were detected as red fluorescence.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g05.gif"/></fig>
<fig id="f7-mmr-07-04-1129" position="float">
<label>Figure 7</label>
<caption>
<p>Quantitative measurement of DNA content in mesenchymal stem cells (MSCs) after culturing with each group for 7 days at 37&#x000B0;C. Mean &#x000B1; standard deviation; n&#x0003D;3. <sup>&#x0002A;</sup>Significantly different from Dulbecco&#x02019;s modified Eagle&#x02019;s medium and fetal bovine serum (DMEM&#x0002B;FBS) group at P&lt;0.05.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g06.gif"/></fig>
<fig id="f8-mmr-07-04-1129" position="float">
<label>Figure 8</label>
<caption>
<p>Expression of early, middle and late osteogenic genes in mesenchymal stem cells (MSCs). (A) Core binding factor &#x003B1;1 (Cbfa1) mRNA expression on day 7; (B) bone sialoprotein (BSP) mRNA expression on day 14; (C) osteocalcin (OCN) mRNA expression on day 21. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the control. Mean &#x000B1; standard deviation; n&#x0003D;3. <sup>&#x0002A;</sup>Significantly different from Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) at P&lt;0.05.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g07.gif"/></fig>
<fig id="f9-mmr-07-04-1129" position="float">
<label>Figure 9</label>
<caption>
<p>Alkaline phosphatase (ALP) activity in mesenchymal stem cells (MSCs) after culturing in extraction solution from each group for 14 and 21 days. Mean &#x000B1; standard deviation; n&#x0003D;3. <sup>&#x0002A;</sup>Significantly different from Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) at P&lt;0.05.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g08.gif"/></fig>
<fig id="f10-mmr-07-04-1129" position="float">
<label>Figure 10</label>
<caption>
<p>Optical micrographs of different groups with Alizarin Red S staining of each group after culturing with medium containing extracts of the glass particle dissolution product for 21 days.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g09.gif"/></fig>
<fig id="f11-mmr-07-04-1129" position="float">
<label>Figure 11</label>
<caption>
<p>Mineralized nodules formation of mesenchymal stem cells (MSCs) after 21 days of culturing in extraction solution from each group. Mean &#x000B1; standard deviation; n&#x0003D;3. <sup>&#x0002A;</sup>Significantly different at P&lt;0.05.</p></caption>
<graphic xlink:href="MMR-07-04-1129-g10.gif"/></fig>
<table-wrap id="tI-mmr-07-04-1129" position="float">
<label>Table I</label>
<caption>
<p>Composition of the groups (mol&#x00025;).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Group</th>
<th align="center" valign="middle">Na<sub>2</sub>O</th>
<th align="center" valign="middle">K<sub>2</sub>O</th>
<th align="center" valign="middle">MgO</th>
<th align="center" valign="middle">CaO</th>
<th align="center" valign="middle">SrO</th>
<th align="center" valign="middle">SiO<sub>2</sub></th>
<th align="center" valign="middle">B<sub>2</sub>O<sub>3</sub></th>
<th align="center" valign="middle">P<sub>2</sub>O<sub>5</sub></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">A: 0Sr</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">2</td></tr>
<tr>
<td align="left" valign="top">B: 3Sr</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">2</td></tr>
<tr>
<td align="left" valign="top">C: 6Sr</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">2</td></tr>
<tr>
<td align="left" valign="top">D: 9Sr</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">2</td></tr>
<tr>
<td align="left" valign="top">E: 12Sr</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">2</td></tr></tbody></table></table-wrap></floats-group></article>
